FDA Publishes Draft Guidance on Financial Disclosure for Clinical Investigators

Summary

The Food and Drug Administration (FDA) has released a draft guidance document to help clinical investigators, industry professionals, and FDA staff understand and comply with regulations related to financial disclosure by clinical investigators, addressing frequently asked questions on the topic.